Remove 2029 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

T2D market growth driven by novel GLP-1RAs and once-weekly basal insulin therapies

Pharmaceutical Technology

billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. billion in 2029, although its sales growth is likely to continue beyond 2029. GlobalData expects that the T2D market will see significant growth from 2019–29, with the 9MM having a total of $45.9

article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

in 2029 , with a compound annual growth rate of 27.9%. In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients.